Trial Profile
Treatment of Crohn's disease-associated refractory diarrhoea with octreotide LAR An open pilot study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Octreotide (Primary) ; Octreotide (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- 08 Jul 2014 New trial record